Identify Prognostic Biomarkers of Lung Cancer

NCT05010330 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-08-18

No results posted yet for this study

Summary

Multi-omics and Clinical Data Analysis is potential to predict the prognosis of lung cancer patients.

Conditions

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Huijing Huang · RenJi Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-09-20
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05010330 on ClinicalTrials.gov